Black Rock Inc. Crispr Therapeutics Ag Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Black Rock Inc. holds 2,777,784 shares of CRSP stock, worth $113 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,777,784

Previous 2,546,361 9.09%

Holding current value

$113 Million

Previous $174 Million 13.56%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$51.17 - $68.18 $11.8 Million - $15.8 Million	231,423 Added 9.09%	2,777,784 $150 Million
Q1 2024 May 10, 2024	BUY	$60.67 - $89.12 $1.81 Million - $2.66 Million	29,875 Added 1.19%	2,546,361 $174 Million
Q4 2023 Feb 13, 2024	SELL	$38.62 - $72.18 $7.6 Million - $14.2 Million	-196,724 Reduced 7.25%	2,516,486 $158 Million
Q3 2023 Nov 13, 2023	SELL	$45.39 - $59.0 $243,517 - $316,535	-5,365 Reduced 0.2%	2,713,210 $123 Million
Q2 2023 Aug 11, 2023	SELL	$43.47 - $67.77 $3.48 Million - $5.42 Million	-80,006 Reduced 2.86%	2,718,575 $153 Million
Q1 2023 May 12, 2023	BUY	$41.0 - $56.12 $6.92 Million - $9.48 Million	168,844 Added 6.42%	2,798,581 $127 Million
Q4 2022 Feb 13, 2023	BUY	$39.19 - $65.67 $11.1 Million - $18.6 Million	283,153 Added 12.07%	2,629,737 $107 Million
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $11.9 Million - $16.3 Million	194,458 Added 9.04%	2,346,584 $153 Million
Q2 2022 Aug 12, 2022	SELL	$43.23 - $73.83 $5.47 Million - $9.35 Million	-126,648 Reduced 5.56%	2,152,126 $131 Million
Q1 2022 May 12, 2022	BUY	$53.19 - $79.24 $53.6 Million - $79.8 Million	1,007,246 Added 79.22%	2,278,774 $143 Million
Q4 2021 Feb 10, 2022	BUY	$70.09 - $111.29 $9.97 Million - $15.8 Million	142,244 Added 12.6%	1,271,528 $96.4 Million
Q3 2021 Nov 09, 2021	BUY	$110.2 - $156.64 $8.68 Million - $12.3 Million	78,736 Added 7.49%	1,129,284 $126 Million
Q2 2021 Aug 11, 2021	BUY	$100.84 - $161.89 $106 Million - $170 Million	1,050,548 New	1,050,548 $170 Million

Others Institutions Holding CRSP

# of Institutions

490

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.18B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account